Sinopharm Hyundai announced on the evening of November 26 that Sinopharm Group Rongsheng Pharmaceutical Co., Ltd., a wholly-owned subsidiary, received the “Drug Supplement Application Approval Notice” for calcium gluconate injections approved and issued by the State Drug Administration, and approved the calcium gluconate injection to pass the consistent evaluation of the quality and efficacy of generic drugs. Calcium gluconate injections are suitable for treating hand and foot cramps caused by calcium deficiency, acute hypokalemia, alkali poisoning, and hypoparathyroid function; allergic diseases; relief from magnesium poisoning; relief from fluorosis; and cardiac resuscitation.

Sinopharm Hyundai announced on the evening of November 26 that Sinopharm Group Rongsheng Pharmaceutical Co., Ltd., a wholly-owned subsidiary, received the “Drug Supplement Application Approval Notice” for calcium gluconate injections approved and issued by the State Drug Administration, and approved the calcium gluconate injection to pass the consistent evaluation of the quality and efficacy of generic drugs. Calcium gluconate injections are suitable for treating hand and foot cramps caused by calcium deficiency, acute hypokalemia, alkali poisoning, and hypoparathyroid function; allergic diseases; relief from magnesium poisoning; relief from fluorosis; and cardiac resuscitation.